Published in Cell on November 24, 1999
Atherosclerosis. Nature (2000) 15.95
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Differential regulation of cell motility and invasion by FAK. J Cell Biol (2003) 3.15
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol (2000) 1.92
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol (2001) 1.91
Is HCMV a tumor promoter? Virus Res (2010) 1.81
Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol (2003) 1.79
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A (2006) 1.71
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol (2002) 1.56
Evidence that dynamin-2 functions as a signal-transducing GTPase. J Cell Biol (2000) 1.53
The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Mol Biol Cell (2001) 1.52
The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (2009) 1.49
Immunity, atherosclerosis and cardiovascular disease. BMC Med (2013) 1.49
Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol (2000) 1.48
Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol (2004) 1.43
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res (2011) 1.36
The chemokine system in arteriogenesis and hind limb ischemia. J Vasc Surg (2007) 1.34
Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol (2006) 1.30
Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol (2008) 1.27
Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc Natl Acad Sci U S A (2001) 1.25
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol (2005) 1.19
Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol (2003) 1.18
Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol (2001) 1.18
Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke (2010) 1.14
Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol (2007) 1.13
Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spread. J Virol (2011) 1.13
Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis (2001) 1.11
Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J Virol (2004) 1.11
Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol (2003) 1.10
Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol (2005) 1.10
Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells. J Virol (2002) 1.07
Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae (2011) 1.05
IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin. Blood (2010) 1.04
Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol (2012) 1.02
Slit proteins, potential endogenous modulators of inflammation. J Neurovirol (2002) 1.02
Constitutive inositol phosphate formation in cytomegalovirus-infected human fibroblasts is due to expression of the chemokine receptor homologue pUS28. J Virol (2003) 1.01
Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes. J Virol (2005) 1.00
The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion. J Virol (2002) 1.00
The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J Virol (2005) 1.00
The role of cytomegalovirus in angiogenesis. Virus Res (2010) 0.99
Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood (2007) 0.97
Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol (2007) 0.97
Patterns of divergence in the vCXCL and vGPCR gene clusters in primate cytomegalovirus genomes. Virology (2009) 0.96
Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J Virol (2004) 0.96
The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. J Virol (2009) 0.95
High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood (2007) 0.95
Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol (2004) 0.95
Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol (Lausanne) (2013) 0.94
Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog (2009) 0.94
The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4. Virology (2013) 0.93
Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. Annu Rev Pharmacol Toxicol (2012) 0.92
Human Cytomegalovirus US28: a functionally selective chemokine binding receptor. Infect Disord Drug Targets (2009) 0.92
A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology. J Infect Dis (2013) 0.92
Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. Neoplasia (2004) 0.92
The carboxy-terminal tail of human cytomegalovirus (HCMV) US28 regulates both chemokine-independent and chemokine-dependent signaling in HCMV-infected cells. J Virol (2009) 0.91
Characterization of the rhesus cytomegalovirus US28 locus. J Virol (2003) 0.91
G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33. J Biol Chem (2006) 0.91
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol (2008) 0.91
Human cytomegalovirus and autoimmune disease. Biomed Res Int (2014) 0.90
Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. J Virol (2006) 0.90
Human cytomegalovirus-encoded pUL7 is a novel CEACAM1-like molecule responsible for promotion of angiogenesis. MBio (2014) 0.89
Cytomegalovirus CC chemokine promotes immune cell migration. J Virol (2012) 0.87
Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus. Comp Med (2008) 0.87
Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J Virol (2003) 0.86
T cell inactivation by poxviral B22 family proteins increases viral virulence. PLoS Pathog (2014) 0.86
Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination. Viruses (2014) 0.86
The human herpesvirus 6 G protein-coupled receptor homolog U51 positively regulates virus replication and enhances cell-cell fusion in vitro. J Virol (2005) 0.86
eXamine: exploring annotated modules in networks. BMC Bioinformatics (2014) 0.86
Functional analysis of human cytomegalovirus pUS28 mutants in infected cells. J Gen Virol (2008) 0.85
HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase. Herpesviridae (2010) 0.85
Kaposi's sarcoma-associated herpesvirus-G protein-coupled receptor-expressing endothelial cells exhibit reduced migration and stimulated chemotaxis by chemokine inverse agonists. J Pharmacol Exp Ther (2009) 0.85
Virus self-improvement through inflammation: no pain, no gain. Proc Natl Acad Sci U S A (2002) 0.85
Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis. Infect Disord Drug Targets (2011) 0.85
Human cytomegalovirus downregulates expression of receptors for platelet-derived growth factor by smooth muscle cells. J Virol (2007) 0.84
Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice. Hum Vaccin Immunother (2012) 0.84
Desensitization of herpesvirus-encoded G protein-coupled receptors. Life Sci (2007) 0.84
Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J Virol (2005) 0.83
Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS One (2008) 0.83
Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies? Trans Am Clin Climatol Assoc (2001) 0.82
US28 is a potent activator of phospholipase C during HCMV infection of clinically relevant target cells. PLoS One (2012) 0.82
Human cytomegalovirus manipulation of latently infected cells. Viruses (2013) 0.81
High Human Cytomegalovirus IgG Level is Associated with Increased Incidence of Diabetic Atherosclerosis in Type 2 Diabetes Mellitus Patients. Med Sci Monit (2015) 0.81
Infection of human cytomegalovirus in cultured human gingival tissue. Virol J (2006) 0.80
Gender differences and age-specific associations between body mass index and other cardiovascular risk factors in CMV infected and uninfected people. Immunol Lett (2014) 0.79
Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization. PLoS Pathog (2012) 0.79
Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options. World J Exp Med (2015) 0.78
Spatiotemporal dynamics of triglyceride storage in unilocular adipocytes. Mol Biol Cell (2014) 0.78
RCMV increases intimal hyperplasia by inducing inflammation, MCP-1 expression and recruitment of adventitial cells to intima. Herpesviridae (2010) 0.77
Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells. J Virol (2004) 0.77
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
Production of single-stranded plasmid DNA. Methods Enzymol (1987) 39.38
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Phytochrome and Seed Germination. I. Temperature Dependence and Relative P(FR) Levels in the Germination of Dark-germinating Tomato Seeds. Plant Physiol (1967) 5.14
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Equity of access to health care services: theory and evidence from the UK. Soc Sci Med (2001) 4.83
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol (1997) 4.17
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol (1989) 3.98
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
BEACHES: an observational system for assessing children's eating and physical activity behaviors and associated events. J Appl Behav Anal (1991) 3.61
Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc (1993) 3.57
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells. Mol Biol Cell (1999) 3.45
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Agriculture. Sustainable intensification in agriculture: premises and policies. Science (2013) 3.24
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet (1998) 3.14
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol (1999) 3.02
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc Natl Acad Sci U S A (1999) 2.91
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Membrane traffic in polarized epithelial cells. Curr Opin Cell Biol (2000) 2.76
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74
Correlates of physical activity at home in Mexican-American and Anglo-American preschool children. Health Psychol (1993) 2.74
Phytochrome and Seed Germination. III. Action of Prolonged Far Red Irradiation on the Germination of Tomato and Cucumber Seeds. Plant Physiol (1967) 2.54
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med (1990) 2.45
NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J Cell Biol (1997) 2.42
Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med (1993) 2.42
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) (1982) 2.39
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med (1983) 2.36
Inferring parameters of mutation, selection and demography from patterns of synonymous site evolution in Drosophila. Genetics (2001) 2.29
Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28
The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27
The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci (2001) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Infection control for home health. Infect Control Hosp Epidemiol (1990) 2.09
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 2.07
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol (1986) 2.05
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis (1997) 2.02
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Evidence for a novel route of wheat storage proteins to vacuoles. J Cell Biol (1992) 2.01
The pFF plasmids: cassettes utilising CaMV sequences for expression of foreign genes in plants. J Biotechnol (1990) 2.00
Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol (1997) 2.00
Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem (1993) 1.99
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 1.98
HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet (1997) 1.95
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
Fulvine and the pulmonary circulation. Thorax (1971) 1.94
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron (1999) 1.94
The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol (2000) 1.92
Do pathogens accelerate atherosclerosis? J Nutr (2001) 1.91
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis (1987) 1.91
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther (2009) 1.90
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169. J Virol (1982) 1.88
Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection. Cancer Res (1977) 1.87
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int J Tuberc Lung Dis (2002) 1.87
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism (2001) 1.87
The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology (1990) 1.85
Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology (2001) 1.85
Arabidopsis consensus intron sequences. Plant Mol Biol (1996) 1.85
Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis (1997) 1.84
Aminorex and the pulmonary circulation. Thorax (1971) 1.83
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer (2009) 1.82
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface. Virology (1993) 1.81
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
A Saccharomyces cerevisiae homologue of mammalian translation initiation factor 4B contributes to RNA helicase activity. EMBO J (1993) 1.80
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77